EVALUATE THE SAFETY AND TOLERABILITY

Clinical trials for EVALUATE THE SAFETY AND TOLERABILITY explained in plain language.

Never miss a new study

Get alerted when new EVALUATE THE SAFETY AND TOLERABILITY trials appear

Sign up with your email to follow new studies for EVALUATE THE SAFETY AND TOLERABILITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New weight loss drug CMS-D008 enters first human tests

Symptom relief Not yet recruiting

This early-stage study tests a new drug, CMS-D008, in healthy and overweight adults to see if it is safe and how the body processes it. About 110 participants will receive either the drug or a placebo through injections. The goal is to gather initial safety data, not to prove wei…

Matched conditions: EVALUATE THE SAFETY AND TOLERABILITY

Phase: PHASE1 • Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. • Aim: Symptom relief

Last updated May 15, 2026 11:56 UTC

EVALUATE THE SAFETY AND TOLERABILITY

Get alerted when new EVALUATE THE SAFETY AND TOLERABILITY trials appear

New weight loss drug CMS-D008 enters first human tests